ChartRow logo
Share this page
TVTX
$49.60-6.04%
as of close, Oct 16, 2026
☾ AH $49.60 -6.04%
PeersMRNALLYMDTUNHJNJTMO

TVTX financial statements

The full income statement, balance sheet, and cash-flow statement for Travere Therapeutics Inc. (TVTX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 76.5M2024-09 78.0M2024-12 88.7M2025-03 88.8M2025-06 89.1M2025-09 89.5M2025-12 92.2M2026-03 93.0M2026-06 94.3M+23.2% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue491M+110.5%233M+60.5%145M+32.7%109M-17.0%132M-33.5%
Cost of revenue10.3M+33.5%7.74M-32.4%11.4M+159.0%4.42M+15.8%3.82M-37.7%
Research & development206M-5.3%217M-11.2%245M+7.8%227M+13.0%201M+52.7%
Selling, general & administrative337M+27.7%264M-0.5%266M+34.4%198M+56.4%126M-7.0%
Restructuring0.00-100.0%2.44M-78.6%11.4M0.000.00
Amortization of intangibles59.2M+41.9%41.7M+15.0%36.3M+95.0%18.6M+68.4%11.0M-50.8%
Operating income-62.8M+80.6%-324M+16.6%-388M-21.4%-320M-60.4%-199M-13.2%
Interest expense10.7M-3.9%11.2M-1.0%11.3M+2.7%11.0M-44.2%19.7M+3.1%
Interest & investment income12.7M-28.6%17.8M-18.2%21.8M+246.8%6.28M+214.9%1.99M-60.2%
Other non-operating income11.6M+448.9%-3.32M-308.2%1.59M+63.7%974K+321.6%231K-83.7%
Pre-tax income-49.3M+84.6%-321M+14.8%-376M-13.6%-331M-52.7%-217M-14.9%
Income tax988K+723.3%120K-46.2%223K-28.8%313K-23.5%409K+102.1%
-25.5M+92.1%-322M-188.6%-111M+60.0%-278M-54.6%-180M-6.3%
Income from continuing operations-50.3M+84.3%-321M+14.8%-376M-13.5%-331M-52.5%-217M
Net income to common-25.5M+92.1%-322M-188.6%-111M+60.0%-278M-54.6%-180M-6.3%
-$0.29+92.9%-$4.08-172.0%-$1.50+65.7%-$4.37-45.2%-$3.01+15.4%
EPS (basic)-$0.29+92.9%-$4.08-172.0%-$1.50+65.7%-$4.37-45.2%-$3.01+15.4%
Weighted-avg shares (basic)89.2M+13.1%78.9M+6.2%74.3M+16.5%63.8M+6.6%59.8M+25.9%
Weighted-avg shares (diluted)89.2M+13.1%78.9M+6.2%74.3M+16.5%63.8M+6.6%59.8M+25.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
438M+5.0%417M-32.4%617M+26.8%486M-16.5%583M+42.0%
Cash & equivalents93.0M+58.9%58.5M+0.6%58.2M-5.7%61.7M-62.8%166M+95.5%
Accounts receivable80.1M+195.5%27.1M+28.0%21.2M+27.2%16.6M+4.6%15.9M-0.1%
Inventory36.2M-13.6%41.9M+344.8%9.41M+108.0%4.52M-38.2%7.31M-3.9%
Prepaid expenses28.8M+126.7%12.7M-34.4%19.3M+60.7%12.0M+79.1%6.72M-17.5%
605M+1.9%594M-24.7%789M+17.3%673M-13.4%777M+27.9%
Property, plant & equipment4.02M-24.6%5.34M-28.7%7.48M-17.3%9.05M-18.5%11.1M+17.9%
Operating lease right-of-use10.6M-26.0%14.3M-20.9%18.1M-14.0%21.0M-9.5%23.2M-9.7%
Goodwill—800K+0.0%800K+0.0%800K-11.1%900K+0.0%
Intangible assets114M+9.5%104M-0.4%104M+7.6%97.1M-34.6%148M-3.7%
Other non-current assets8.88M-51.1%18.2M+70.4%10.7M-0.2%10.7M-3.5%11.1M+41.7%
160M-20.3%201M+12.8%178M+25.1%142M+14.6%124M+33.9%
Accounts payable24.8M+5.4%23.5M-43.5%41.7M+141.0%17.3M+14.2%15.1M+24.8%
Accrued liabilities126M+46.5%86.0M-27.7%119M+24.3%95.7M+27.4%75.2M+32.4%
Deferred revenue—2.81M-60.3%7.10M-40.7%12.0M-26.4%16.3M
Current lease liability5.88M+8.7%5.41M+10.1%4.91M+10.7%4.43M+13.4%3.91M+994.7%
Other current liabilities3.19M-81.3%17.1M+226.6%5.24M-8.5%5.72M-7.5%6.19M+3.5%
490M-8.4%535M-9.0%588M-6.6%630M+32.7%475M+19.8%
Deferred revenue (non-current)——1.83M-83.2%10.9M-46.4%20.4M
Non-current lease liability11.1M-35.2%17.2M-24.0%22.6M-17.8%27.5M-12.7%31.5M+11.2%
Operating lease liability (total)17.0M-24.7%22.6M-17.9%27.5M-13.8%31.9M-9.8%35.4M+2.6%
Other non-current liabilities7.60M+11.8%6.80M-34.1%10.3M+10.0%9.38M-23.6%12.3M+0.7%
115M+94.4%59.1M-70.6%201M+368.6%42.9M-85.8%302M+43.0%
Preferred stock0.000.000.000.000.00
Common stock9.00K+0.0%9.00K+28.6%7.00K+16.7%6.00K+0.0%6.00K+20.0%
Additional paid-in capital1.59B+5.5%1.51B+13.4%1.33B+25.3%1.06B-0.8%1.07B+33.9%
Retained earnings-1.47B-1.8%-1.45B-28.6%-1.13B-11.0%-1.01B-32.4%-766M-30.7%
Accumulated other comprehensive income-1.19M-1386.3%-80.0K+94.5%-1.46M+49.9%-2.91M-417.3%-562K+37.7%
Total liabilities & equity605M+1.9%594M-24.7%789M+17.3%673M-13.4%777M+27.9%
Common shares issued90.9M+4.0%87.5M+16.0%75.4M+17.2%64.3M+2.9%62.5M+19.6%
Common shares outstanding90.9M+4.0%87.5M+16.0%75.4M+17.2%64.3M+2.9%62.5M+19.6%
Shares outstanding (cover)92.2M+3.9%88.7M+16.6%76.1M+17.5%64.7M+2.4%63.2M+4.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
37.8M+115.9%-237M+15.2%-280M-50.3%-186M-1159.4%-14.8M+65.4%
Depreciation & amortization60.7M+39.5%43.6M+13.0%38.5M+86.0%20.7M+62.6%12.7M-48.1%
Intangible amortization59.2M+41.9%41.7M+15.0%36.3M+95.0%18.6M+68.4%11.0M-50.8%
Share-based compensation44.9M+21.6%36.9M-16.6%44.2M+16.0%38.1M+29.0%29.6M+25.2%
Deferred income taxes0.000.000.000.000.00
Change in receivables27.8M+363.6%6.00M-46.7%11.3M+962.6%1.06M+224.3%-853K+62.9%
Change in inventory-5.02M-233.0%3.77M-90.4%39.4M+3160.5%1.21M+1133.3%-117K-102.3%
Change in payables———2.31M-16.7%2.77M+145.9%
27.9M-71.9%99.3M+78.1%55.8M+271.3%-32.6M+76.3%-138M-124.4%
Capital expenditure——668K+249.7%191K-96.3%5.10M-24.6%
Free cash flow——-281M-50.5%-186M-837.4%-19.9M+59.8%
Acquisitions0.000.000.000.000.00-100.0%
Other investing activities404K+910.0%40.0K-94.0%668K-15.5%791K0.00
-33.5M-124.0%139M-36.3%219M+86.1%118M-49.3%232M+81.4%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.00-100.0%135M-29.5%191M0.00-100.0%189M
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
FX effect on cash2.29M+350.9%-913K-146.1%1.98M+170.9%-2.79M-263.1%1.71M+231.1%
Net change in cash34.5M+9510.0%359K+110.2%-3.51M+96.6%-104M-228.5%81.0M+262.6%
Interest paid8.84M+0.0%8.84M+0.0%8.84M-13.0%10.2M+38.7%7.33M+6.2%
Income taxes paid—453K-21.6%578K-42.0%996K+106.1%-16.4M-386.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap3.52B+128.0%1.55B+128.8%676M-49.9%1.35B-31.2%1.96B+19.5%
P/S7.2×+8.3%6.6×+27.1%5.2×-83.9%32.4×+117.4%14.9×+79.8%
P/B30.7×+17.3%26.2×+983.6%2.4×-82.0%13.4×+106.4%6.5×-16.4%
Source filing10-K10-K10-K10-K10-K

About this data

Source: TVTX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TVTX filings on SEC EDGAR → Not investment advice.